Bioneer Corporation (KOSDAQ:064550)
11,000
+2,210 (25.14%)
Sep 1, 2026, 3:30 PM KST
Bioneer Revenue
Bioneer had revenue of 96.15B KRW in the quarter ending June 30, 2026, with 8.91% growth. This brings the company's revenue in the last twelve months to 345.88B, up 15.87% year-over-year. In the year 2025, Bioneer had annual revenue of 330.11B with 12.29% growth.
Revenue (ttm)
345.88B
Revenue Growth
+15.87%
P/S Ratio
0.82
Revenue / Employee
882.35M
Employees
392
Market Cap
283.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 330.11B | 36.14B | 12.29% |
| Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
| Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
| Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
| Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GC Cell | 162.00B |
| MEDIPOST | 74.84B |
| HLB Therapeutics | 64.45B |
| GC Genome | 32.64B |
| SillaJen | 10.92B |
| Anterogen.Co.,Ltd. | 8.37B |
| Genexine | 5.81B |
| Genomictree | 2.95B |